Related Experiment Video
Updated: Jun 15, 2026

Expression, Solubilization, and Purification of Eukaryotic Borate Transporters
Published on: March 7, 2019
Regulated transport of sulfate and oxalate by SLC26A2/DTDST
John F Heneghan1, Arash Akhavein, Maria J Salas
1Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Abstract:
Nephrolithiasis in the Slc26a6(-/-) mouse is accompanied by 50-75% reduction in intestinal oxalate secretion with unchanged intestinal oxalate absorption. The molecular identities of enterocyte pathways for oxalate absorption and for Slc26a6-independent oxalate secretion remain undefined. The reported intestinal expression of SO(4)(2-) transporter SLC26A2 prompted us to characterize transport of oxalate and other anions by human SLC26A2 and mouse Slc26a2 expressed in Xenopus oocytes. We found that hSLC26A2-mediated [(14)C]oxalate uptake (K(1/2) of 0.65 +/- 0.08 mM) was cis-inhibited by external SO(4)(2-) (K(1/2) of 3.1 mM). hSLC26A2-mediated bidirectional oxalate/SO(4)(2-) exchange exhibited extracellular SO(4)(2-) K(1/2) of 1.58 +/- 0.44 mM for exchange with intracellular [(14)C]oxalate, and extracellular oxalate K(1/2) of 0.14 +/- 0.11 mM for exchange with intracellular (35)SO(4)(2-). Influx rates and K(1/2) values for mSlc26a2 were similar. hSLC26A2-mediated oxalate/Cl(-) exchange and bidirectional SO(4)(2-)/Cl(-) exchange were not detectably electrogenic. Both SLC26A2 orthologs exhibited nonsaturable extracellular Cl(-) dependence for efflux of intracellular [(14)C]oxalate, (35)SO(4)(2-), or (36)Cl(-). Rate constants for (36)Cl(-) efflux into extracellular Cl(-), SO(4)(2-), and oxalate were uniformly 10-fold lower than for oppositely directed exchange. Acidic extracellular pH (pH(o)) inhibited all modes of hSLC26A2-mediated anion exchange. In contrast, acidic intracellular pH (pH(i)) selectively activated exchange of extracellular Cl(-) for intracellular (35)SO(4)(2-) but not for intracellular (36)Cl(-) or [(14)C]oxalate. Protein kinase C inhibited hSLC26A2 by reducing its surface abundance. Diastrophic dysplasia mutants R279W and A386V of hSLC26A2 exhibited similar reductions in uptake of both (35)SO(4)(2-) and [(14)C]oxalate. A386V surface abundance was reduced, but R279W surface abundance was at wild-type levels.
Insights
The SLC26A2 transporter facilitates oxalate and sulfate transport in the intestine, impacting nephrolithiasis. This study characterizes SLC26A2
Area of Science:
- Molecular biology
- Physiology
- Nephrology
Background:
- Nephrolithiasis is associated with reduced intestinal oxalate secretion in Slc26a6(-/-) mice.
- The specific enterocyte pathways for oxalate absorption and Slc26a6-independent secretion remain unclear.
- Intestinal expression of the sulfate transporter SLC26A2 suggests a potential role in anion transport.
Purpose of the Study:
- To investigate the transport of oxalate and other anions by human SLC26A2 and mouse Slc26a2.
- To characterize the kinetic properties and regulatory mechanisms of SLC26A2-mediated transport.
Main Methods:
- Expression of human SLC26A2 and mouse Slc26a2 in Xenopus oocytes.
- Measurement of radiolabeled oxalate, sulfate, and chloride uptake and exchange.
- Assessment of transport inhibition by varying substrate concentrations, pH, and protein kinase C activity.
- Analysis of transport in diastrophic dysplasia mutants of SLC26A2.
Main Results:
- SLC26A2 mediates saturable uptake of oxalate with cis-inhibition by sulfate.
- SLC26A2 facilitates bidirectional exchange of oxalate/sulfate and sulfate/chloride, which is not detectably electrogenic.
- Extracellular chloride dependence was observed for efflux, and acidic extracellular pH inhibited all SLC26A2-mediated exchanges.
- Acidic intracellular pH selectively activated chloride/sulfate exchange, and protein kinase C inhibited SLC26A2 by reducing surface abundance.
- Diastrophic dysplasia mutants showed reduced uptake of sulfate and oxalate, with altered surface abundance.
Conclusions:
- SLC26A2 functions as a key transporter of oxalate and sulfate in the intestine.
- SLC26A2 plays a role in Slc26a6-independent intestinal oxalate secretion.
- Understanding SLC26A2 transport mechanisms and regulation is crucial for managing nephrolithiasis.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Secondary Active Transport
Secondary Active Transport
Secondary Active Transport
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

